{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:51:06Z","timestamp":1791363066136,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003751","name":"Gobierno de Espana Ministerio de Sanidad Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","award":["2024I026"],"award-info":[{"award-number":["2024I026"]}],"id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.puhe.2026.106490","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:56:57Z","timestamp":1789070217000},"page":"106490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Global prevalence and patterns of benzodiazepine use among adolescents and young adults: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8481-3261","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Ortega-Sus\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-8952","authenticated-orcid":false,"given":"Teresa","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores Remedios","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-8768","authenticated-orcid":false,"given":"Elena","family":"Gonz\u00e1lez-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.puhe.2026.106490_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits. A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.puhe.2026.106490_bib2","doi-asserted-by":"crossref","first-page":"165.e1","DOI":"10.1016\/j.anpedi.2016.06.005","article-title":"Insomnio en ni\u00f1os y adolescentes. Documento de consenso","volume":"86","author":"Pin","year":"2017","journal-title":"Anales de Pediatr\u00eda"},{"key":"10.1016\/j.puhe.2026.106490_bib3","article-title":"Benzodiazepines: how they work and how to withdraw","author":"Ashton","year":"2002","journal-title":"The Ashton Manual"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib4","first-page":"113","article-title":"Benzodiazepines and related sedatives","volume":"106","author":"Peng","year":"2022","journal-title":"Medical Clinics"},{"issue":"suppl 1","key":"10.1016\/j.puhe.2026.106490_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.puhe.2026.106490_bib6","series-title":"Gu\u00eda de Consenso Para El Buen Uso de Benzodiacepinas : Gesti\u00f3n de Riesgos y Beneficios. 2a","author":"Lligo\u00f1a Garreta","year":"2019"},{"key":"10.1016\/j.puhe.2026.106490_bib7","series-title":"Generalised Anxiety Disorder and Panic Disorder in Adults: Management","year":"2019"},{"issue":"10","key":"10.1016\/j.puhe.2026.106490_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad124","article-title":"Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis","volume":"46","author":"Ma","year":"2023","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12877-024-04742-7","article-title":"Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries","volume":"24","author":"Luka\u010di\u0161inov\u00e1","year":"2024","journal-title":"BMC Geriatr"},{"issue":"Journal Article","key":"10.1016\/j.puhe.2026.106490_bib10","article-title":"Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use","volume":"16","author":"Roncero","year":"2025","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.puhe.2026.106490_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2024-003233","article-title":"Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia","volume":"13","author":"Pe\u00f1arrubia-Mar\u00eda","year":"2025","journal-title":"Family Medicine and Community Health"},{"issue":"15","key":"10.1016\/j.puhe.2026.106490_bib12","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/ijerph16152735","article-title":"The global prevalence of anxiety among medical students: a meta-analysis","volume":"16","author":"Quek","year":"2019","journal-title":"Int J Environ Res Publ Health"},{"issue":"2","key":"10.1016\/j.puhe.2026.106490_bib13","first-page":"791","article-title":"Brief report: a population-based study of the impact of the COVID-19 pandemic on benzodiazepine use among children and young adults","volume":"34","author":"Antoniou","year":"2025","journal-title":"EurChild AdolescPsychiatry"},{"issue":"3","key":"10.1016\/j.puhe.2026.106490_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/medsci13030164","article-title":"Use of benzodiazepines in medical students: a comparative analysis between medical and other university degrees","volume":"13","author":"Fern\u00e1ndez de Frutos","year":"2025","journal-title":"Med Sci"},{"key":"10.1016\/j.puhe.2026.106490_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"Journal Article","key":"10.1016\/j.puhe.2026.106490_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.puhe.2021.02.036","article-title":"COgnitive enhancement and consumption of psychoactive substances among Youth students (COSYS): a cross-sectional study in France","volume":"194","author":"Batisse","year":"2021","journal-title":"Public Health"},{"issue":"4","key":"10.1016\/j.puhe.2026.106490_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/camh.12716","article-title":"Trends in the nonmedical misuse of benzodiazepines and Z-hypnotics among school-aged adolescents (2016-2021): gender differences and related factors","volume":"29","author":"Carrasco-Garrido","year":"2024","journal-title":"Child Adolesc Ment Health"},{"key":"10.1016\/j.puhe.2026.106490_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1129447","article-title":"Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the national survey on drug use and health","volume":"14","author":"McHugh","year":"2023","journal-title":"Front Psychiatr"},{"issue":"7","key":"10.1016\/j.puhe.2026.106490_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jama.2024.12030","article-title":"Adolescent use, diversion sources, and perceived procurement difficulty of prescription medications","volume":"332","author":"McCabe","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.puhe.2026.106490_bib20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/add.16359","article-title":"Drug overdose risk with benzodiazepine treatment in young adults: comparative analysis in privately and publicly insured individuals","volume":"119","author":"Bushnell","year":"2024","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.puhe.2026.106490_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002635","article-title":"Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study","volume":"15","author":"Sidorchuk","year":"2018","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.puhe.2026.106490_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/cap.2017.0140","article-title":"Decreasing trend in the use and long-term use of benzodiazepines among young adults","volume":"28","author":"T\u00e4hk\u00e4p\u00e4\u00e4","year":"2018","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.puhe.2026.106490_bib23","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.puhe.2026.106490_bib24","article-title":"Opioid and benzodiazepine use among adolescents and young adults in Denmark","volume":"72","author":"Kl\u00e6rke","year":"2025","journal-title":"Danish Medical Journal"},{"issue":"9","key":"10.1016\/j.puhe.2026.106490_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.puhe.2026.106490_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/jebm.12445","article-title":"The Freeman\u2013Tukey double arcsine transformation for the meta-analysis of proportions: recent criticisms were seriously misleading","volume":"14","author":"Doi","year":"2021","journal-title":"J Evid Base Med"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12874-025-02527-z","article-title":"Overcoming challenges in prevalence meta-analysis: the case for the Freeman-Tukey transform","volume":"25","author":"Abdulmajeed","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.puhe.2026.106490_bib29","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (Updated August 2024)","author":"Higgins","year":"2024"},{"issue":"3","key":"10.1016\/j.puhe.2026.106490_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"},{"issue":"5","key":"10.1016\/j.puhe.2026.106490_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized Linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.puhe.2026.106490_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ajad.13481","article-title":"Opioid and benzodiazepine misuse in the United States: the impact of socio\u2010demographic characteristics","volume":"33","author":"Haider","year":"2024","journal-title":"Am J Addict"},{"key":"10.1016\/j.puhe.2026.106490_bib34","article-title":"A decade of benzodiazepine and Z-drug use in Hong Kong: a longitudinal study","volume":"59","author":"Lee","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.puhe.2026.106490_bib35","first-page":"1","article-title":"Benzodiazepine misuse and alcohol co-use in college student drinkers: motives and adverse mental health outcomes","author":"Paul","year":"2025","journal-title":"J Am Coll Health"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63037-4","article-title":"Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study","volume":"14","author":"Thomas","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.puhe.2026.106490_bib37","first-page":"234","article-title":"Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults","volume":"61","author":"Toce","year":"2023","journal-title":"ClinToxicol"},{"issue":"3","key":"10.1016\/j.puhe.2026.106490_bib38","first-page":"186","article-title":"High prevalence and early onsets: legal and illegal substance use in an urban cohort of young adults in Switzerland","volume":"28","author":"Quednow","year":"2022","journal-title":"EurAddictRes"},{"issue":"20","key":"10.1016\/j.puhe.2026.106490_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192013213","article-title":"Toxic habits and well-being measures in Spanish healthcare university students during the COVID-19 pandemic","volume":"19","author":"Zapata","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"issue":"5","key":"10.1016\/j.puhe.2026.106490_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.pain.2013.01.011","article-title":"Medical use, medical misuse, and nonmedical use of prescription opioids: results from a longitudinal study","volume":"154","author":"McCabe","year":"2013","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.puhe.2026.106490_bib41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/bcp.14604","article-title":"Medicine misuse: a systematic review and proposed hierarchical terminology","volume":"87","author":"Singier","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.puhe.2026.106490_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/dar.13979","article-title":"Impact of \u201cstreet\u201d benzodiazepines on drug-related deaths in England, Wales and Northern Ireland","volume":"44","author":"Rock","year":"2025","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"10.1016\/j.puhe.2026.106490_bib43","doi-asserted-by":"crossref","first-page":"956","DOI":"10.17269\/s41997-023-00784-3","article-title":"The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive study","volume":"114","author":"Campbell","year":"2023","journal-title":"Can J Public Health"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350626003598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350626003598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:05:56Z","timestamp":1791360356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350626003598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0033350626003598"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2026.106490","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global prevalence and patterns of benzodiazepine use among adolescents and young adults: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2026.106490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}],"article-number":"106490"}}